PATENT CLAIM ANALYSIS

Application Number: 15972738
Application Type: Utility
Filing Date: 2018-05
Publication Date: 2019-04
Patent Classification: ["514", "291000"]

Abstract:
The present invention relates to a sterile pharmaceutical composition comprising tiotropium or a pharmaceutically acceptable salt thereof, for inhalation via nebulization to a subject (e.g. a human). The invention also relates to a process for preparing the pharmaceutical composition and its use in the treatment of respiratory diseases such as chronic obstructive pulmonary disease (COPD) in a subject.

Claim (Index 3):
A composition according to  claim 1 , wherein tiotropium is present in an amount of about 0.001 mg to about 0.3 mg.

Metadata:
- Claim Count in Document: 5.0
- Percentile: 93.0
- Lexical Diversity: 1.43478
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['15663246', '15157143', '15783146', '11506128', '10644333']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.763887400289212
- 35 USC 102 Novelty (BERT): 0.5763341927930489
- Combined Prediction Score: 0.7451320795395957
- Mean Citation Score: 326.910472
- Max Citation Score: 439.32996
- Similarity Product: 435.90743591900826

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 0

Dataset: test